Literature DB >> 2895395

Hepatotoxicity of tetrahydroaminoacridine.

D J Ames, P S Bhathal, B M Davies, J R Fraser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895395     DOI： 10.1016/s0140-6736(88)91636-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.

Authors:  G Chatellier; L Lacomblez
Journal:  BMJ       Date:  1990-02-24

2.  Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro.

Authors:  M F Braga; A L Harvey; E G Rowan
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 3.  A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.

Authors:  S C Samuels; K L Davis
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.228

Review 4.  Tetrahydroaminoacridine (THA) in Alzheimer's disease.

Authors:  J Byrne; T Arie
Journal:  BMJ       Date:  1989-04-01

Review 5.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

6.  Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment.

Authors:  Jan Korabecny; Kamil Musilek; Ondrej Holas; Eugenie Nepovimova; Daniel Jun; Filip Zemek; Veronika Opletalova; Jiri Patocka; Vlastimil Dohnal; Florian Nachon; Jana Hroudova; Zdenek Fisar; Kamil Kuca
Journal:  Molecules       Date:  2010-12-02       Impact factor: 4.411

Review 7.  Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations.

Authors:  Samuele Maramai; Mohamed Benchekroun; Moustafa T Gabr; Samir Yahiaoui
Journal:  Biomed Res Int       Date:  2020-06-30       Impact factor: 3.411

Review 8.  Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity.

Authors:  Todd J Eckroat; Danielle L Manross; Seth C Cowan
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.